Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Xgeva

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



donor kidney1 - laser light1 - catheter1 - fecal incontinence3 - blood test4 - recurrent infection2 - vigorous activity1 - kidney pelvis1 - ifosfamide1 - renal cells2 - adrenocortical carcinoma1 - urinary proteins2 - alport disease1 - journal of rheumatology1 - nuclear scintigraphy4 - creatinine test1 - hair loss1 - advanced prostate cancer8 - epidemiology1 - diarrhea1 - uterine cancer4 - bone decay1 - fluid intake1 - american urological association5 - urinary disease1 - egfr1 - aua1 - chronic diarrhea3 - renal ectopia1 - urinary obstruction1 -